Concepedia

Ola M. Saad

OM

Statistics

Publications

42

Citations

3.8K

H-Index

27

Active since

2003

Affiliations

Bioanalytica (Switzerland)(Current)

University of California, Berkeley

Genesys (United States)

University of California, Davis

AbbVie (United States)

Ola M. Saad is an author at Bioanalytica (Switzerland) specializing in pharmacology, pharmacy, and pharmacokinetics of monoclonal antibodies.

ORCID

Publications per year

2003–2024

42

Publications

42

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

Ben‐Quan Shen, Keyang Xu, Luna Liu et al. · Nature Biotechnology · 2012 · 999 citations

, , +17

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Sandhya Girish, Manish Gupta, Bei Wang et al. · Cancer Chemotherapy and Pharmacology · 2012 · 265 citations · Full text

, , +17

Bioanalytical Assay Strategies for The Development of Antibody–Drug Conjugate Biotherapeutics

Surinder Kaur, Keyang Xu, Ola M. Saad et al. · Bioanalysis · 2013 · 232 citations

, , +17

Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)

Hirdesh Uppal, Estelle Doudement, Kaushiki Mahapatra et al. · Clinical Cancer Research · 2014 · 211 citations

, , +17

Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats

C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang et al. · Bioconjugate Chemistry · 2011 · 204 citations

, , +17

1–5 of 42